Monday, October 2, 2023
Monday, October 2, 2023

Contact: 561.316.3330

6 US Health Systems Announce Strategic Alliance to Share Ideas, Promote Best Practices and Advance Human Resources Innovations

6 US Health Systems that are nationally-ranked announced the formation of the Evolve Health Alliance, a unique human resources alliance that will work collectively to address key functional areas that will improve the diversity, well-being and engagement of their respective workforces and, ultimately, improve patient care in their respective communities.

The alliance and its members operate hospitals, outpatient facilities and other care sites throughout the United States. Since the early days of the COVID-19 pandemic, these organizations have shared ideas and best practices so each can more effectively support their individual workforces in the ever-changing health care environment. Now, these organizations will collectively develop new resources so each is better positioned to take on some of the most pressing issues their workforces face today and into the future.

Included in the initial phase of information sharing are: best practices regarding initiatives that focus on the well-being of employees; workforce data and analytics insights into how human capital programs and operations can be redefined; collaboration to enhance innovation and implementation of diversity and inclusion programs; ad hoc reciprocal agreements to help address staffing needs; and enabling human resources teams to remain ahead of the curve amid continuously changing external factors.

The learning environment created from this alliance is expected to be pivotal for each organization as it prepares for future challenges within healthcare. With a focus on the betterment of patient care, these member organizations are poised to take on the road ahead of them:

  • AdventHealth, Altamonte Springs, Florida
  • Atrium Health, Charlotte, North Carolina
  • Henry Ford Health System, Detroit, Michigan
  • Intermountain Healthcare, Salt Lake City, Utah
  • Northwell Health, New Hyde Park, New York
  • OhioHealth, Columbus, Ohio

“Collaboration is key for health care systems to successfully adapt to changing conditions and prepare for the future,” said Heather Brace, senior vice president and chief people officer of Intermountain Healthcare, who also serves as co-chair of Evolve Health Alliance. “We know this alliance will help us evolve policies, practices and initiatives that ultimately benefit our patients and the communities we serve.”

Maxine Carrington, senior vice president and chief people officer at Northwell Health, and the Alliance’s other co-chair said, “Health systems around the country relied on each other’s expertise during the pandemic in ways we had not experienced before. We knew clinically that we were stronger together in advancing patient care, but we also recognized the benefit of collaborating with innovative and like-minded health systems to better prepare our workforces for the future,” adding, “We are eager to work with our colleagues to push health care boundaries to meet our goals.”

A trigger point in forming the alliance came during the height of the COVID-19 pandemic, when Northwell Health and Intermountain Healthcare worked collaboratively to address each system’s projected staffing shortfalls due to surges in the number of patients coming to their care sites. To meet demand, Intermountain deployed 48 team members to Northwell, which later reciprocated. Positive staff feedback led to the idea of forming a broader alliance.

Additionally, the collective organizations will collaborate on leadership development programs where members from each organization are able to participate in skills development programming at other alliance member organizations. These shared development opportunities among clinical and non-clinical staff, as well as administrative and operational teams, will enable an exchange of ideas, processes and best practices that will benefit each organization.

Medical Device News Magazine
Our publication is dedicated to bringing our readers the latest medical device news. We are proud to boast that our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall purpose and objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

4SC Receives Orphan Drug Designation (ODD) for resminostat (Kinselby) in CTCL from the US FDA

Jason Loveridge, Ph.D., CEO of 4SC, commented: “Receiving orphan drug designation for resminostat provides us with a number of important benefits, most crucially 7 years’ market exclusivity in the US, a key foundation of our efforts to commercialise Kinselby.  We are currently preparing a marketing authorisation application for Kinselby in the EU, which remains on track for submission in Q1 2024.”

Abyrx Receives FDA Clearance for MONTAGE ® Settable Bone Putty for Use in Cardiothoracic Surgery

By expanding the range of FDA-cleared surgical applications for MONTAGE, this latest milestone positions Abyrx to build upon the more than 25,000 units of MONTAGE that have been used to date by surgeons in trauma, orthopedics, sports medicine, foot and ankle, and craniomaxillofacial procedures.

FDA Grants Fast Track Designation to 9MW3011

9MW3011 has been approved to clinical study by NMPA and FDA, respectively. The first person has been dosed in the clinical study in China in March, 2023.

MicuRx receives FDA Qualified Infectious Disease Product (QIDP) and Fast Track Designation for Contezolid and Contezolid acefosamil

"We are pleased to gain the QIDP and Fast Track designations for DFI as recognition that contezolid and contezolid acefosamil are novel new agents to meet an important unmet need in this common and challenging infection", stated Dr Zhengyu Yuan, Chief Executive Officer at MicuRx. 

Via Nova Therapeutics Announces FDA clearance of Investigational New Drug (IND) Application for VNT-101

"We look forward to evaluating VNT-101 in the clinic," said Don Ganem MD, Co-Founder and CEO of Via Nova Therapeutics. "This is an important step to developing a flu antiviral with a novel mechanism of action, and a milestone for Via Nova Therapeutics as we advance our first compound into the clinic."

By using this website you agree to accept Medical Device News Magazine Privacy Policy